Electrochemical Activation of Ni–Fe Oxides for the Oxygen Evolution Reaction in Alkaline Media
ACS Catalysis · 2025-07-04 · 15 (13) · 11475-11486
DOI: 10.1021/acscatal.5c02405 ↗At a glance
Journal article in ACS Catalysis, published online on 2025-06-18. Written by Emily K Volk and 6 co-authors. Institution: Advanced Energy Systems Graduate Program, Colorado School of Mines, Golden, Colorado 80401, United States. Cited 41 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Renewable Energy Laboratory, Hydrogen and Fuel Cell Technologies Office.
Abstract (original language)
The oxygen evolution reaction (OER) is essential to many key electrochemical devices, including H2O electrolyzers, CO2 electrolyzers, and metal-air batteries. NiFe oxides have been historically identified as active for the OER, though they have been less studied in their more commercially relevant bulk oxide forms, such as NiFe2O4. Past works have demonstrated that the initial starting phase of Ni-(Fe) precatalysts can influence their activation to the Ni-(Fe)-OOH active phase, including the rate and degree of conversion, pointing to the necessity of understanding activation protocols and in situ characteristics of catalyst materials at the device level. In this work, we investigate the characteristics of commercially relevant NiFe bulk oxides (NiFe2O4 and a physical mixture of NiO and γ-Fe2O3) during multiple activation procedures. Our results demonstrate that significant performance enhancement is observed for these bulk oxides regardless of the Fe incorporation in the initial form (i.e., atomically or macroscopically integrated), leading to significant performance enhancement (up to 30×) over time on stream. We hypothesize that this activation is due to the formation of NiFeOOH active sites on the surface, supported by in situ cyclic voltammetry and Raman spectroscopy results. We further show that not only the starting material but also the method of activation influences the number of Ni-(Fe)-OOH active sites formed and suggest that these sites can be quantified from the Ni2+ to Ni3+ redox transition using cyclic voltammetry. Broadly, this work demonstrates the necessity of in situ characterization of catalyst materials for cell-level design and testing.
Subjects
Author keywords
Authors and institutions
- Advanced Energy Systems Graduate Program, Colorado School of Mines, Golden, Colorado 80401, United States.
- Chemistry and Nanoscience Center, National Renewable Energy Laboratory, Golden, Colorado 80401, United States.
- Department of Chemistry, University of Puerto Rico - Rio Piedras, San Juan, PR 00925-2537, United States.
- Department of Materials Science and Engineering, Norwegian University of Science and Technology (NTNU), Trondheim N-7491, Norway.
- Department of Chemical and Biological Engineering, Colorado School of Mines, Golden, Colorado 80401, United States.
ORCID profiles: Emily K Volk, Melissa E Kreider, Svein Sunde, Shaun M Alia, Stephanie Kwon
Funding
- National Renewable Energy Laboratory
- Hydrogen and Fuel Cell Technologies Office
Cite
APA
Volk, E. K., Kreider, M. E., Gibson Colón, D. M., Müller, M., Sunde, S., Alia, S. M., & Kwon, S. (2025). Electrochemical Activation of Ni–Fe Oxides for the Oxygen Evolution Reaction in Alkaline Media. ACS Catalysis, 15(13), 11475-11486. https://doi.org/10.1021/acscatal.5c02405
Vancouver
Volk EK, Kreider ME, Gibson Colón DM, Müller M, Sunde S, Alia SM, et al. Electrochemical Activation of Ni–Fe Oxides for the Oxygen Evolution Reaction in Alkaline Media. ACS Catalysis. 2025;15(13):11475-11486. doi:10.1021/acscatal.5c02405
BibTeX
@article{Volk2025,
author = {Volk, Emily K and Kreider, Melissa E and Gibson Colón, Daniella M and Müller, Magdalena and Sunde, Svein and Alia, Shaun M and Kwon, Stephanie},
title = {Electrochemical Activation of Ni–Fe Oxides for the Oxygen Evolution Reaction in Alkaline Media},
journal = {ACS Catalysis},
year = {2025},
volume = {15},
number = {13},
pages = {11475--11486},
doi = {10.1021/acscatal.5c02405}
}
EUVIMED